Interestingly, a loss of CDK13 gene copies was significantly associated with early-onset of HCC, whereas high gene-copy numbers (i.e., amplification) was significantly associated with late-onset of HCC. This evidence concerns the gene CDK13 and hepatocellular carcinoma.